Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Rismani

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Biomolecular Structure & Dynamics|July 22, 2020
Computational evaluation of a fusion protein consisted of pertussis toxin and filamentous hemagglutinin from <i>Bordetella pertussis</i> to target Claudin-4 using C-terminal fragment of <i>Clostridium perfringens</i> enterotoxinNegar Souod, Elham Rismani, Fariborz Bahrami, et al.
Parasites & Vectors|January 31, 2020
Molecular characterization of RNase III protein of Asaia sp. for developing a robust RNAi-based paratransgensis tool to affect the sexual life-cycle of Plasmodium or Anopheles fitnessMajid Asgari, Mahdokht Ilbeigikhamsehnejad, Elham Rismani, et al.
Molecular and Cellular Biochemistry|August 30, 2025
Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapiesFaezeh Sharafi, Elham Rismani, Mohamad Rhmanian, et al.
Computer Methods and Programs in Biomedicine|January 23, 2025
Targeting CD84 protein on myeloid-derived suppressor cells as a novel immunotherapy in solid tumorsSaeed Mobini, Milad Chizari, Elham Rismani, et al.
Malaria Journal|January 26, 2026
Inhibition of carboxypeptidase b1 from Anopheles stephensi by the potato carboxypeptidase inhibitor: a foundational step toward paratransgenesis-based malaria controlZahra Monshizadeh, Elham Rismani, Fatemeh Abdi, et al.
Journal of Biomolecular Structure & Dynamics|November 6, 2020
Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathwayLadan Mafakher, Elham Rismani, Hamzeh Rahimi, et al.
ACS Chemical Neuroscience|December 7, 2020
NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme CellsMahmoud Gharbavi, Behrooz Johari, Elham Rismani, et al.
Expert Opinion on Therapeutic Targets|February 22, 2025
Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinomaElham Rismani, Nikoo Hossein-Khannazer, Moustapha Hassan, et al.
Oncology Research|January 8, 2024
Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cellsRoghayeh Ghorbani, Mahmoud Gharbavi, Ali Sharafi, et al.
Journal of Cellular Physiology|May 23, 2019
Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT)Zahra Bigdelou, Behrooz Johari, Mehdi Kadivar, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Biomolecular Structure & Dynamics|July 22, 2020
Computational evaluation of a fusion protein consisted of pertussis toxin and filamentous hemagglutinin from <i>Bordetella pertussis</i> to target Claudin-4 using C-terminal fragment of <i>Clostridium perfringens</i> enterotoxinNegar Souod, Elham Rismani, Fariborz Bahrami, et al.
Parasites & Vectors|January 31, 2020
Molecular characterization of RNase III protein of Asaia sp. for developing a robust RNAi-based paratransgensis tool to affect the sexual life-cycle of Plasmodium or Anopheles fitnessMajid Asgari, Mahdokht Ilbeigikhamsehnejad, Elham Rismani, et al.
Molecular and Cellular Biochemistry|August 30, 2025
Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapiesFaezeh Sharafi, Elham Rismani, Mohamad Rhmanian, et al.
Computer Methods and Programs in Biomedicine|January 23, 2025
Targeting CD84 protein on myeloid-derived suppressor cells as a novel immunotherapy in solid tumorsSaeed Mobini, Milad Chizari, Elham Rismani, et al.
Malaria Journal|January 26, 2026
Inhibition of carboxypeptidase b1 from Anopheles stephensi by the potato carboxypeptidase inhibitor: a foundational step toward paratransgenesis-based malaria controlZahra Monshizadeh, Elham Rismani, Fatemeh Abdi, et al.
Journal of Biomolecular Structure & Dynamics|November 6, 2020
Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathwayLadan Mafakher, Elham Rismani, Hamzeh Rahimi, et al.
ACS Chemical Neuroscience|December 7, 2020
NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme CellsMahmoud Gharbavi, Behrooz Johari, Elham Rismani, et al.
Expert Opinion on Therapeutic Targets|February 22, 2025
Targeting glypican 3 by immunotoxins: the promise of immunotherapy in hepatocellular carcinomaElham Rismani, Nikoo Hossein-Khannazer, Moustapha Hassan, et al.
Oncology Research|January 8, 2024
Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cellsRoghayeh Ghorbani, Mahmoud Gharbavi, Ali Sharafi, et al.
Journal of Cellular Physiology|May 23, 2019
Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT)Zahra Bigdelou, Behrooz Johari, Mehdi Kadivar, et al.
Pageof 5